Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0040822 (
tremor
)
18,428
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Autosomal recessive hereditary spastic paraplegia (AR HSP) with thin corpus callosum (TCC) is a rare neurodegenerative disorder often caused by mutations in the gene encoding for spatacsin at the
SPG11
locus on chromosome 15q. The disease is characterized by progressive spastic paraparesis and mental retardation which occur during the first two decades of life and frequently with peripheral neuropathy. Brain magnetic resonance imaging (MRI) reveals typical TCC with periventricular white matter changes. We describe two patients, of Turkish descent, from the same consanguineous family and affected with
SPG11
in association with unusual early-onset parkinsonism. Parkinsonism occurred during the very early stages of
SPG11
in both patients, being in one the inaugural symptom of the disease presented as a resting
tremor
with akinesia, rigidity and expressing an initial moderate levodopa-response that progressively weakened. The second patient presented a resting
tremor
with mild akinesia and no levodopa-response. Both patients were affected with progressive spastic paraparesis which had initially occurred at 15 and 12 years of age, respectively, in association with mild mental retardation and an axonal polyneuropathy. TCC with periventricular white matter changes (PWMC) was evident by MRI and (123)I-ioflupane SPECT was abnormal. Genetic analysis detected for both patients a new c.704_705delAT, p.H235RfsX12 homozygous mutation in
SPG11
. This report provides evidence that parkinsonism may initiate
SPG11
-linked HSP TCC and that
SPG11
may cause juvenile parkinsonism.
...
PMID:SPG11 spastic paraplegia. A new cause of juvenile parkinsonism. 1922 11